BSS Plus 250
"The U.S. Food and Drug Administration today approved Vimizim (elosulfase alfa), the first FDA-approved treatment for Mucopolysaccharidosis Type IVA (Morquio A syndrome). Morquio A syndrome is a rare, autosomal recessive lysosomal storage disease "...
BSS Plus 250 mL
BSS Plus 250 mL
- Clinician Information:
BSS Plus 250 Side Effects Center
Medical Editor: John P. Cunha, DO, FACOEP
BSS Plus (balanced salt solution enriched with bicarbonate, dextrose, and glutathione) is surgical aid used as an intraocular irrigating solution during intraocular surgical procedures involving perfusion of the eye. This medication is available in generic form. Common side effects include postoperative inflammatory reactions as well as incidents of corneal edema and corneal decompensation.
Dosage of BSS Plus is determined by a physician. BSS Plus may interact with other drugs. Tell your doctor all medications and supplements you use. Tell your doctor if you are pregnant or plan to become pregnant before receiving BSS Plus. Consult your doctor before breastfeeding.
Our BSS Plus (balanced salt solution enriched with bicarbonate, dextrose, and glutathione) Side Effects Drug Center provides a comprehensive view of available drug information on the potential side effects when taking this medication.
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
What is Prescribing information?
The FDA package insert formatted in easy-to-find categories for health professionals and clinicians.
BSS Plus 250 FDA Prescribing Information: Side Effects
Additional BSS Plus 250 mL Information
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Find out what women really need.